SCHEMBL9056147

SCHEMBL9056147

C=CCCn1cnc2c1c(=O)n(CCCCC(C)(C)O)c(=O)n2C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 8/20 0.56
▸ PDE4A P27815 4/20 0.56
▸ PDE4B Q07343 3/20 0.56
▸ PDE4C Q08493 3/20 0.56
▸ PDE4D Q08499 3/20 0.56
▸ ADORA2A P29274 2/20 0.56
▸ LMNA P02545 3/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ NFKB1 P19838 2/20 0.53
▸ ACHE P22303 2/20 0.53
▸ PMP22 Q01453 2/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ ADORA1 P30542 1/20 0.49
▸ RXFP1 Q9HBX9 2/20 0.47
▸ TNF P01375 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9056755 0.90 ADORA2B (0.61) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL10346307 0.90 LMNA (0.61) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL5427270 0.87 PDE4A (0.70) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL7358934 0.86 PDE4A (0.69) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL7030926 0.86 PDE4A (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL19601304 0.85 PDE4A (0.58) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL10346304 0.85 LMNA (0.56) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL11461780 0.85 PDE4A (0.69) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL11461750 0.85 PDE4A (0.69) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL9056239 0.85 PDE4A (0.54) ADORA2BPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0413278-B1 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN (JP) 1996-11-06 — — EP claimed
EP-0413278-A2 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN LIMITED (JP) 1991-02-20 — — EP claimed
EP-0413278-B1 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN (JP) 1996-11-06 — — EP disclosed
US-5109003-A METHOD FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1992-04-28 — — US disclosed
EP-0413278-A2 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN LIMITED (JP) 1991-02-20 — — EP disclosed
EP-0268585-B1 TERTIARY HYDROXYALKYLXANTHINES, THEIR MANUFACTURING PROCESS, MEDICINES CONTAINING THEM AND USE THEREOF HOECHST AKTIENGESELLSCHAFT (DE) 1990-05-30 — — EP disclosed
US-4833146-A BRAINS, BLOOD DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-23 — — US disclosed
Send feedback